|Applications||ELISA, ICC/IF, IHC-F, IHC-P, WB|
|Application Note||WB(1:100-500), ELISA(1:500-1000), IHC-P(1:100-500), IHC-F(1:100-500), IF(1:100-500)|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by Protein A and peptide affinity chromatography.|
|Full Name||B-cell CLL/lymphoma 9|
|Product Description||Rabbit Polyclonal antibody to BCL9|
|Background||BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]|
|Synonyms||B-cell CLL/lymphoma 9 Antibody, LGS Antibody|
|Immunogen||KLH conjugated synthetic peptide derived from human BCL9|
|Species Reactivity||Human, Mouse, Rat|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Bovine, Rabbit, Horse, Sheep, Pig, Chicken, Dog|